Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,041.49
-1.4646-0.07%
Number of Gainers:555
Number of Losers:446
Number of Flat:18
PE:- -
High:2,046.28
Open:2,042.95
Low:2,040.86
Close:2,042.95
Volume:2.01B
Turnover:263.40B
Market Cap:97.51T
Float Cap:91.28T

Loading ...

Lululemon Announces New Leadership Team Structure to Drive Next Chapter of Growth

THOMSON REUTERS
·
Oct 08

Starbucks - Annualized Dividend Rate is $2.52 Per Share

THOMSON REUTERS
·
Oct 08

Starbucks Announces Increase in Quarterly Cash Dividend

THOMSON REUTERS
·
Oct 08

Lululemon Leadership Reshuffle Includes Departures and New Positions

Dow Jones
·
Oct 08

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

GlobeNewswire
·
Oct 08

Lululemon Reorganizes Executive Ranks

Dow Jones
·
Oct 08

Lululemon Operations Consolidated Under Former Walmart Executive

Dow Jones
·
Oct 08

Fed Minutes: All 19 Policymakers Backed September Rate Increase, Most Eye Another Hike This Year, Hinting No Urgency for October

Deep News
·
Oct 08

FIFA Says Unpaid Court Sanction over Alleged AI Misuse Justifies Tossing Antitrust Lawsuit

Reuters
·
Oct 08

Baidu Shifts to Dual Primary Listing in Hong Kong Effective Sept. 1, 2026

Reuters
·
Oct 08

Intl Flavors & Fragrances is Maintained at Buy by Citigroup

Dow Jones
·
Oct 08

ConnectM Principal Financial Officer Mahesh Choudhury Acquires $3,497 of Common Shares

Reuters
·
Oct 08

AGNC Declares October 2026 Dividend of $0.12 Per Common Share

Reuters
·
Oct 08

North Haven Net REIT - Sells 2,835,825 Common Shares for $59.60 Mln on Oct 1, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 08

BCB Bancorp Adds Steven Gallotta, Denny Kim to Boards of Directors

Reuters
·
Oct 08

FormFactor to Report Fiscal Q3 2026 Results, Host Conference Call

Reuters
·
Oct 08

Expedia Group Schedules Webcast for Third-Quarter 2026 Results

Reuters
·
Oct 08

Lululemon's New Execs Face Major Product Problems

Dow Jones
·
Oct 08

vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease

GlobeNewswire
·
Oct 08

UK MHRA Revokes Valneva Chikungunya Vaccine Ixchiq Marketing Authorization After Benefit-Risk Review

Reuters
·
Oct 08